The effect of age and weight on the response to formalin inactivated, alum-adjuvanted hepatitis A vaccine in healthy adults

Vaccine

Volumn 15, Issue 10, 1997, Pages 1157-1161

  Reuman, Peter D ^a   Kubilis, Paul ^b   Hurni, William ^c   Brown, Leora ^c   Nalin, David ^c  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

age; hepatitis A vaccine; skin fold; weight

Indexed keywords

ADJUVANT; ALUMINUM POTASSIUM SULFATE; FORMALDEHYDE; HEPATITIS A VACCINE;

ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BODY WEIGHT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; HUMAN EXPERIMENT; IMMUNE RESPONSE; INTRAMUSCULAR DRUG ADMINISTRATION; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKINFOLD THICKNESS; VACCINATION;

ADOLESCENT; ADULT; AGE FACTORS; ALUM COMPOUNDS; BODY MASS INDEX; BODY WEIGHT; FEMALE; FORMALDEHYDE; HEPATITIS A ANTIBODIES; HEPATITIS A VACCINES; HEPATITIS ANTIBODIES; HEPATOVIRUS; HUMANS; IMMUNOSORBENT TECHNIQUES; MALE; MIDDLE AGED; SAFETY; SKINFOLD THICKNESS; VACCINES, INACTIVATED; VIRAL HEPATITIS VACCINES;

EID: 0030806460     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(96)00310-6     Document Type: Article

References (17)

1. Hadler, S.C. Global impact of hepatitis A virus infection: changing patterns. In: Viral Hepatitis and Liver Disease. Proceedings of the 1990 International Symposium on Viral Hepatitis and Liver Disease: Contemporary Issues and Prospects (Eds Hollinger, F.B., Lemon, S.M. and Margolis, H.). Williams and Wilkins, Baltimore, 1991, pp. 14-20
2. Carisson, R.M., Claesson, B.A. and Iwarson, S.A. Dose response study of an inactivated hepatitis A virus vaccine. J. Hepatol. 1993, 18, S41-S45
3. Block, S.L., Hedrick, J.A. and Tyler, R.D. et al. Safety, tolerability and immunogenicity of a formalin inactivated hepatitis A vaccine (VAQTA®) in rural Kentucky children. Pediatr. Infect. Dis. J. 1993, 12, 976-980
4. Provost, P.J., Hughes, J.V., Miller, W.J., Giesa, P.A., Banker, F.S. and Emini, E.A. An inactivated hepatitis A viral vaccine of cell culture origin. J. Med. Virol. 1986, 19, 23-31
5. Safford, S.E.S., Needleman, S.B. and Decker, R.H. Radio-immunoassay for detection of antibody to hepatitis A virus. Results of clinical evaluation. Am. J. Clin. Pathol. 1980, 74, 25-31
6. Miller, W.J., Clark, W., Hurni, W., Kuter, B., Schofield, T. and Nalin, D. Sensitive assays for hepatitis A antibodies. J. Med. Virol. 1993, 41, 201-204
7. Provost, P.J., Bishop, R.P. and Gerety, R.J. et al. New findings in live attenuated hepatitis A vaccine development. J. Med. Virol. 1986, 20, 165-175
8. Gerety, R.J., Smallwood, L.A., Finlayson, J.S. and Tabor, E. Standardization of the antibody to hepatitis A virus (anti-HAV) content of immunoglobulin. Dev. Biol. Stand. 1983, 54, 411-416
9. Fagiolo, U., Amadori, A. and Cozzi, E. et al. Humoral and cellular immune response to influenza virus vaccination in aged humans. Aging Milano. 1993, 5, 451-458
10. Smith, P.W., Roccaforte, J.S. and Daly, P.B. Infection and immune response in the elderly. Ann. Epidemiol. 1992, 2, 813-822
11. Nalin, D.R., Kuter, B.J. and Brown, L. et al. Worldwide experience with CR326F-derived inactivated hepatitis A virus vaccine in pediatric and adult populations: an overview. J. Hepatol. 1993, 18, S51-S55
12. Nalin, D.R. Hepatitis A vaccines. Curr. Opin. Invest. Drugs 1993, 2, 899-903
13. Shouval, D., Ashur, Y. and Adler, R. et al. Single and booster dose responses to an inactivated hepatitis A virus vaccine: comparison with immune serum globulin prophylaxis. Vaccine 1993, 11, S9-S14
14. Nalin, D.R., Kuter, B.J. and Brown, L. et al. Worldwide experience with the CR 326F-derived inactivated hepatitis A virus vaccine in pediatric and adult populations: an overview. Hepatology 1993, Suppl. 2, S51-S55
15. Nalin, D.R. Hepatitis A vaccines. Curr. Opin. Invest. Drugs 1993, 2, 899-903
16. Villarejos, V.M., Serra, C.J., Anderson-Visona, K. and Mosley, J.W. Hepatitis A virus infection in households. Am. J. Epidemiol. 1982, 115, 577-586
17. Shaw, F.E., Guess, H.A. and Roets, J.M. et al. Effect of anatomic injection site, age and smoking on the immune response to hepatitis B vaccination. Vaccine 1989, 7, 425-430